Swiss generics and biosimilars major Sandoz (SIX: SDZ) today presented its net sales update for the first quarter of 2025.

In a recent study conducted by Navaneethan and colleagues and published in the International Society of Nephrology, the ...

US-Ireland drugmaker Shorla Oncology has received approval from the US regulator for a new multi-dose vial of Tepylute ...

US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) today announced financial results for the first quarter of 2025, showing ...

Shares of US clinical-stage biotech Biohaven (NYSE: BHVN) rose 9.6% to $21.74 yesterday, after it announced an agreement with ...

Pfizer reported first-quarter 2025 earnings on Tuesday that beat Wall Street expectations, boosted by ongoing cost-cutting ...

Italian pharma major Recordati (RECI: MI) has set new three-year financial targets for the period 2025-2027, aiming for ...

The European Commission has approved the conversion of the conditional marketing approval (CMA) into a standard marketing ...

A precision oncology company specializing in blood- and tissue-based genomic profiling to inform cancer treatment decisions.

Granite Bio AG, a clinical-stage immunology company based in Basel, Switzerland, and San Francisco, California, emerged from ...

The Novo Nordisk Foundation has opened its largest research funding initiative, the Challenge Programme, to applicants based outside Denmark for the first time, allowing researchers from the European ...

Early-stage biotech Nova Anchora has secured a new investment to move its lead therapy for epidermolysis bullosa (EB) closer ...